Papers to be presented at the symposium will offer novel research into heretofore little-understood links between latent and persistent infectious agents (such as viruses and bacteria) and cardiovascular disease, and will discuss promising implications for its prevention and treatment offered by advanced biopharmaceuticals such as interferon and human growth hormone.
Speakers will represent cutting-edge medical research institutions from
Improving early detection, prevention, and treatment of cardiovascular disease is a key healthcare challenge for independent
MaxWell Biocorporation, LLC (http://www.max-well.com), is a U.S.-based, privately-held international medical and pharmaceutical company with wholly owned subsidiaries and affiliates in
"We Help You Live Longer" Contact: Alex Meerovich A.Meerovich@max-well.com 202-454-3403 Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Kenneth Alibek https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=78826 Peter Leitner https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=78827
SOURCE MaxWell Biocorporation, LLC